These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 1847212

  • 1. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ, Knight DL, Ritchie JC, Nemeroff CB.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [Abstract] [Full Text] [Related]

  • 2. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ, Knight DL, Ritchie JC, Nemeroff CB.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [Abstract] [Full Text] [Related]

  • 3. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

  • 4. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal.
    Owens MJ, Vargas MA, Knight DL, Nemeroff CB.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):349-56. PubMed ID: 1649300
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute alcohol administration stimulates the activity of hypothalamic neurons that express corticotropin-releasing factor and vasopressin.
    Rivier C, Lee S.
    Brain Res; 1996 Jul 08; 726(1-2):1-10. PubMed ID: 8836539
    [Abstract] [Full Text] [Related]

  • 10. Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.
    Wilson MA, Biscardi R, Smith MD, Wilson SP.
    J Pharmacol Exp Ther; 1996 Sep 08; 278(3):1073-82. PubMed ID: 8819488
    [Abstract] [Full Text] [Related]

  • 11. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
    Naert G, Ixart G, Tapia-Arancibia L, Givalois L.
    Neuroscience; 2006 May 12; 139(2):779-89. PubMed ID: 16457953
    [Abstract] [Full Text] [Related]

  • 12. Effect of repeated exposure to alcohol on the response of the hypothalamic-pituitary-adrenal axis of the rat: I. Role of changes in hypothalamic neuronal activity.
    Lee S, Schmidt ED, Tilders FJ, Rivier C.
    Alcohol Clin Exp Res; 2001 Jan 12; 25(1):98-105. PubMed ID: 11198721
    [Abstract] [Full Text] [Related]

  • 13. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
    Francis AB, Pace TW, Ginsberg AB, Rubin BA, Spencer RL.
    Neuroscience; 2006 Sep 01; 141(3):1503-15. PubMed ID: 16806720
    [Abstract] [Full Text] [Related]

  • 14. Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain.
    Owens MJ, Edwards E, Nemeroff CB.
    Eur J Pharmacol; 1990 Nov 06; 190(1-2):113-22. PubMed ID: 1963847
    [Abstract] [Full Text] [Related]

  • 15. Basal and PAF-, interleukin 1-, ether stress-induced hypothalamic pituitary adrenal secretion of conscious rat: modulation by PAF antagonists.
    Rougeot C, Tiberghein C, Minary P, Dray F.
    J Lipid Mediat; 1991 Nov 06; 4(1):45-59. PubMed ID: 1654152
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M, Cover PO, Poyser RH, Buckingham JC.
    Br J Pharmacol; 1997 Jun 06; 121(3):459-68. PubMed ID: 9179387
    [Abstract] [Full Text] [Related]

  • 17. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
    Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ.
    J Pharmacol Exp Ther; 1996 Oct 06; 279(1):351-8. PubMed ID: 8859013
    [Abstract] [Full Text] [Related]

  • 18. Cocaine-reinforced responding in rhesus monkeys: pharmacological attenuation of the hypothalamic-pituitary-adrenal axis response.
    Broadbear JH, Winger G, Woods JH.
    J Pharmacol Exp Ther; 1999 Sep 06; 290(3):1347-55. PubMed ID: 10454513
    [Abstract] [Full Text] [Related]

  • 19. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z, Csabafi K, Palotai M, Jászberényi M, Földesi I, Gardi J, Szabó G, Telegdy G.
    Neuropeptides; 2014 Feb 06; 48(1):15-20. PubMed ID: 24331779
    [Abstract] [Full Text] [Related]

  • 20. [Role of the neurohypophysis in psychological stress].
    Scantamburlo G, Ansseau M, Legros JJ.
    Encephale; 2001 Feb 06; 27(3):245-59. PubMed ID: 11488255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.